The study used a randomized complete block design (blocking factor was date of start on test) with 5 treatments: 1) physically castrated barrows (PC), 2) intact males (IM), 3) gilts (G), 4) immunologically castrated barrows (IC), and 5) immunologically castrated barrows fed ractopamine at 5 mg/kg (IC+RAC). The study used 192 pigs and was performed from the 16 wk of age (67.2 ± 2.52 kg BW) to a pen mean BW of 132.5 ± 3.60 kg. For IC+RAC, ractopamine was fed for the final 23 d of the study. Pigs were housed in groups of 4 (10 groups for PC, IM, G, and IC and 8 groups for IC+RAC) in a finishing building at a floor space of 1.18 m 2 /pig. Diets were formulated to meet requirements of IM except that the diet for the IC+RAC fed during the ractopamine feeding period was formulated to meet requirements of pigs on that treatment. Pigs had ad libitum access to feed and water throughout the study period and were individually weighed at the start, wk 2 and 4, and subsequently every week until the end of study. For the overall study period, IC had greater (P ≤ 0.05) ADG than the other genders (1,150, 1,024, 1,064, and 954 g/d for IC, PC, IM, and G, respectively; SEM = 25.8) and required fewer days to reach slaughter weight than the other genders (58.1, 61.6, 61.6, and 66.5 d for IC, PC, IM, and G, respectively; SEM = 1.26). Overall ADFI was less (P ≤ 0.05) for IM and G than IC and PC, which were similar (P > 0.05) in this respect (3.11, 3.06, 2.68, and 2.75 kg/d for IC, PC, IM, and G, respectively; SEM = 0.061). Overall G:F was greater (P ≤ 0.05) for IM than the other genders; IC had greater overall G:F than PC and G, which were similar in this respect (0.371, 0.335, 0.397, and 0.347 kg/kg for IC, PC, IM, and G, respectively; SEM = 0.0068). Immunologically castrated barrows had greater (P ≤ 0.05) ADG (30.7%) and ADFI (22.5%) than PC from the second week following the second Improvest dose to the end of the study. During the ractopamine feeding period, IC+RAC had greater (P ≤ 0.05) ADG (11.6%) and G:F (17.3%) than IC. The results of this study confirmed previously observed gender differences and effects of ractopamine on growth performance and that IC grew faster and had greater feed efficiency than PC during the study period.
INTRODUCTION
Using intact males rather than physically castrated barrows for pork production would improve feed efficiency and carcass leanness (Campbell et al., 1989; Dunshea et al., 2001; Pauly et al., 2009 ). However, intact males can produce pork with boar taint, the unpleasant odor released when meat from some intact males is cooked (Williams et al., 1963; Patterson, 1968) . Countries that currently produce intact males, such as the United Kingdom and Australia, minimize the risk of boar taint with varying success by harvesting pigs at relatively young ages and light weights. However, in most countries male pigs are physically castrated early in life to eliminate the risk of boar taint. Gonadotropin releasing factor analogdiphtheria toxoid conjugate (GnRFA; Improvest; Zoetis, Kalamazoo, MI), a product that immunologically castrates male pigs, has been approved for use in a number of countries. It is given in 2 doses with the second dose, generally given in the late finishing phase, effectively castrating the male. Use of this product allows the growth performance advantages of intact males early in the growth period to be exploited while greatly reducing the risk of boar taint developing later. Most published studies with this product have been performed to relatively light final live weights. For example, final BW in the studies of Jaros et al. (2005) , Rikard-Bell et al. (2009) , and Braña et al. (2013) were approximately 105, 108, and 110 kg, respectively.
Ractopamine (Paylean; Elanco Animal Health, Greenfield, IN) is used in late finishing to improve growth performance and carcass leanness (Apple et al., 2007) . However, there is little research evaluating the impact of feeding ractopamine to immunologically castrated barrows at heavy weights. Therefore, the objective of this study was to compare the growth performance of immunologically castrated barrows (with or without ractopamine) and other genders to relatively heavy harvest live weights.
MATERIALS AND METhODS
The study was conducted at the Swine Research Center of the University of Illinois and the experimental protocol for the study was approved by the University of Illinois Institutional Animal Care and Use Committee.
Experimental Design and Treatments
The growth study was conducted as a randomized complete block design with 5 treatments: 1) physically castrated barrows (PC), 2) intact males (IM), 3) gilts (G), 4) immunologically castrated barrows (IC), and 5) immunologically castrated barrows fed ractopamine at 5 mg/kg (IC+RAC; Paylean 9; Elanco Animal Health, Greenfield, IN). Date of start on the study was used as the blocking factor. The study was performed from a fixed time (approximately 16 wk of age; 67.2 ± 2.52 kg BW) to a pen mean BW of 132.5 ± 3.60 kg.
The GnRFA product was administered via subcutaneous injection into the postauricular region of the neck. A safety injector (Model 2 mL Sekurus; Simcro, Hamilton, New Zealand) was used, which had a dual safety system providing both a needle guard and a mechanism to prevent accidental operation of the trigger. Each IM pig received two 2-mL doses of the product. The first dose was administered at wk 16 of age and the second dose was administered 4 wk (28 d) after the first dose. The product was administered as a sterile solution with each milliliter containing 0.2 mg gonadotropin releasing factor analog-diphtheria toxoid conjugate, 150 mg of diethylaminoethyl-dextran hydrochloride, 1 mg chlorocresol, sodium hydroxide as needed to adjust pH, and water (Zoetis, 2013) .
As a check that the immunization had been effective in castrating the pigs, the animals were observed for signs of boar behavior (mounting and riding of other pigs in the pen; Puls et al., 2013) . In addition, a quality assurance inspection was performed by trained operatives 14 d after the second dose during which testicle size and boar behavior were observed. One pig was observed exhibiting boar behavior (sexual mounts) and this animal was administered a third dose of Gn-RFA product 14 d after the second dose.
For the IC+RAC treatment, the ractopamine feeding period was from 1 wk after the second Improvest dose (i.e., end of wk 5 of study) to the end of the study period (average feeding period of 23 d).
Animals and Allotment to Growth Study
A total of 192 pigs that were the progeny of Genetiporc G-Performer sires mated to Genetiporc Fertilis 25 dams (Genetiporc, Alexandria, MN) were used in the study. These were housed in 48 pens of 4 pigs and there were 10 pens of PC, IM, G, and IC and 8 pens of IC+RAC.
At birth, piglets were weighed, and, within a litter, male piglets of similar birth weight were randomly assigned to either be physically castrated or left intact (ratio of 1 male physically castrated to 3 males left intact). Physical castration was performed at 4 d of age. Piglets weighing less than 1 kg at birth were not included in the study.
Allotment to the growth study was performed within gender at approximately 15 wk of age (58.4 ± 2.53 kg BW). Replicates consisted of 5 pens (3 pens of IM, 1 pen of G, and 1 pen of PC). For the allotment of the IM pens, pigs were weighed individually and formed into outcome groups of 3 pigs of similar BW and were randomly allotted from within outcome group to 1 of 3 pens. This process was repeated until there were 4 pigs per pen and the mean pen BW and variation in BW within the 3 pens was similar and representative of the population of IM available at the time of allotment. Pens were checked to ensure litter mates were allotted to different treatments with pigs being moved to achieve this. Pens were randomly allotted to 1 of the 3 IM treatments. For the G and PC treatments, within replicate, pigs that were littermates of the IM were formed into pens of 4 such that the mean pen BW and variation in BW was representative of the population of each gender available at the time of allotment. After allotment, pigs were allowed a 1-wk acclimation period before the start of the growth study.
Animal Housing and Management
From birth to the start of the growth study, pigs were managed according to standard unit protocols.
Piglets were born in standard farrowing accommodation and weaned at 20 ± 1 d of age. In the nursery and grower periods, pigs were housed in mixed-gender groups of 6 pigs and had ad libitum access to standard corn-soybean meal-based diets that were formulated to meet or exceed the nutrient requirements of IM recommended by the NRC (1998).
During the study period, pigs were housed in a mechanically ventilated building that had part-solid, partslotted concrete floors. Pen divisions and gates consisted of vertical steel rods and pen dimensions were 2.59 by 1.83 m, which provided a floor space of 1.18 m 2 /pig. Each pen had a single-space dry-box feeder mounted on the front gate and a nipple-type water drinker. The thermostat was set at 18.5°C throughout the study period and ambient temperature was maintained using thermostatically controlled heaters and fan ventilation.
Diets and Feeding
A 3-phase dietary program (Table 1 ) was used and diets were fed according to a feed budget. The amount fed of the first and second phases were 65.0 and 62.5 kg/pig, respectively; the third phase was fed to the end of the study period. The diets were formulated to meet the nutrient requirements of IM recommended by the NRC (1998). A different diet was used for the third phase for the IC+RAC treatment during the ractopamine feeding period from 1 wk after the second dose (i.e., end of wk 5 of study) until the end of the study period and this was formulated to meet or exceed the nutrient requirements of IC+RAC (A. M. Gaines, The Maschhoffs, Carlyle, IL, personal communication). All diets were based on corn and soybean meal and were offered in meal form. Diet formulations and calculated composition of the diets fed during the experimental period are presented in Table 1 . Pigs had ad libitum access to feed and water throughout the study period.
Measurements
Pigs were weighed at the start and on d 14 and 28 of study and, subsequently, every week until the end of the study. Feed additions to the feeders were recorded and feeders were weighed each time pig weights were taken and used to calculate ADFI and G:F.
Statistical Analysis
The PROC UNIVARIATE procedure of SAS (SAS Inst. Inc., Cary, NC) was used to verify normality and homogeneity of variances of the variables. All data conformed to normality assumptions and were analyzed using the PROC MIXED procedure of SAS (Littell et al., 1996) . Pen was the experimental unit for all measurements, and the model used accounted for the fixed effect of treatment and the random effects of block and replicate. Least squares means for the PC, IM, G, and IC treatments were separated using the PDIFF option of SAS with means being considered different at a P ≤ 0.05. Means for the IC and the IC+RAC treatments were compared using an orthogonal contrast. 
RESULTS AND DISCUSSION

Effects of Gender
Least-squares means for the effect of gender on growth performance are presented in Table 2 . Physically castrated barrows were heavier (P ≤ 0.05) at the start of the study compared to the other genders, which had similar (P > 0.05) BW. Within replicate, the pigs of the different genders were from the same litters and, therefore, of a similar age at the start of the study. This approach was used to ensure that a representative sample of each gender, in terms of age, BW, and litter of origin, was used in the study and to correspond to manufacturer's recommendations with respect to the timing of administration of Improvest (Zoetis, 2013) . Consequently, gender differences in BW at the start of study are likely to reflect gender differences in pretest growth rates. However, growth performance before the start of test was not measured directly in this study.
For the first 4 wk of the study, between the first and second GnRFA product dose, G had lower (P ≤ 0.05) ADG than the other 3 genders, which had similar (P > 0.05) growth rates (Table 2 ). Physically castrated barrows had greater (P ≤ 0.05) ADFI than the other 3 genders, which were similar (P > 0.05) in this respect. Gain:feed ratio was similar (P > 0.05) for IM and IC and was greater (P ≤ 0.05) for these 2 genders than for PC and G, which had similar (P > 0.05) feed efficiency. During the period from the second dose to slaughter, IC grew faster (P ≤ 0.05) than the other genders, which had similar (P > 0.05) growth rates (Table 2 ). In addition, IC had greater (P < 0.05) ADFI than IM and G, with PC being intermediate to and different (P ≤ 0.05) from the other genders for feed intake. Intact males had greater (P ≤ 0.05) G:F ratio than the other genders; IC had greater (P ≤ 0.05) feed efficiency than PC, with G being intermediate to and not different (P > 0.05) from these 2 genders for feed efficiency (Table 2) . 1 PC = physically castrated barrows; IM = intact males; G = gilts; IC = immunologically castrated barrows; IC+RAC = immunologically castrated barrows fed ractopamine at 5 mg/kg.
2 RAC = ractopamine (Paylean 9; Elanco Animal Health, Greenfield, IN) was included in the diet (at 5 mg/kg) and fed from wk 5 of the study period until end of test for an average of 23 d.
3 Means for the IC and IC+RAC treatments were compared using orthogonal contrasts.
For the overall study period (i.e., from first dose to end of test), G had similar (P > 0.05) ADG and G:F but lower (P ≤ 0.05) ADFI than PC (Table 2) . Immunologically castrated barrows had greater (P ≤ 0.05) ADG than the other genders, required fewer (P ≤ 0.05) days to reach slaughter weight, and had greater (P ≤ 0.05) ADFI than IM and G but not (P > 0.05) PC. In addition, overall G:F ratio was greater (P ≤ 0.05) for IC than PC and G; however, IM that had greater (P ≤ 0.05) feed efficiency than the other genders ( Table 2 ).
The majority of research studies with growing-finishing pigs published in the United States over recent years have used PC and G and, consequently, there is limited recently published information on the relative performance of all of the genders that were compared in the current study. In addition, direct comparison of the results of experiments that have evaluated any of these genders with those of the present study is difficult because of differences in the methodology used across studies, particularly as it relates to start and end weights, and the length of the study period.
In the present study, G had similar overall growth rate and feed efficiency but lower feed intake than PC. In agreement with these results, some studies have shown similar growth rates for these 2 genders (Campbell et al., 1989; Morales et al., 2010) ; however, in other studies, G have been shown to grow slower than PC (Dunshea et al., 2001; Hamilton et al., 2003; Fàbrega et al., 2010) . Cisneros et al. (1996) reported similar overall feed efficiency for G and PC, which is similar to the results of the present study. In contrast, however, some studies have reported greater feed efficiency for G compared to PC (Hamilton et al., 2003; Latorre et al., 2004) .
The finding that IM and PC grew at similar rates in all study periods was somewhat surprising given that a number of previous studies have shown that PC have generally grown faster than IM (Zeng et al., 2002; Pauly et al., 2009 ). However, much of the previous research on the relative performance of IM and PC has been performed to lighter final weights than used in the current study. In addition, the lower feed intake and greater feed efficiency of the IM compared to the PC found in the present study is in line with most previous research (Bonneau et al., 1994; Pauly et al., 2009; Fàbrega et al., 2010) .
The similar growth performance of IM and IC in the period between first and second dose was expected given that the IC had received only the first priming dose of GnRFA and would be physiologically similar to the IM during this period (Millet et al., 2011) .
The most relevant practical comparison in relation to the performance of the IC is with the PC that they would replace if this technology was adopted commercially. There have been a number of studies that have evaluated the growth performance of IC and PC during the period from the first dose to harvest and these have produced variable results. For example, Batorek et al. (2012) performed a study during this period with individually housed pigs and found that IC grew faster than PC, which is similar to the results of the current study. In contrast, a number of studies have reported similar growth rate for these 2 genders during this period (Bonneau et al., 1994; Pauly et al., 2009; Andersson et al., 2012) . In these studies, the first product dose was given at younger ages and lighter weights than in the current study, and, consequently, growth performance was measured over a different weight range and, therefore, and as discussed previously, care must be taken when comparing these results with those of the current study.
In the period before the second dose, PC had greater feed intake and grew at a similar rate to IC. However, from second dose to the end of the study, IC had substantially greater feed intake (14%) and growth rates (23%) than PC. A number of studies have shown greater feed intake for IC compared to PC in the period following second GnRFA product dose. For example, Fàbrega et al. (2010) found that IC consumed 19% more feed than PC during this period (86 to 115 kg BW). In contrast, some studies have shown similar feed intake for these 2 genders (Morales et al., 2010 (Morales et al., , 2011 or a lower feed intake for IC (Bonneau et al., 1994) in the period from the second GnRFA product dose to harvest. The reasons for this difference between studies in the relative feed intake of these 2 genders after the second dose is not clear and warrants further study. Despite this variation between studies in the difference between PC and IC for feed intake, the majority of published studies have shown greater growth rates for IC than PC in the period following the second dose, ranging from relatively small (5%; Batorek et al., 2012) to relatively large (>30%; Fàbrega et al., 2010; Schmidt et al., 2011) differences, which is in line with the results of the current study.
The growth performance of the 4 genders for each week of the 4-wk period following second dose (i.e., wk 5 to 8 of the study) is presented in Fig. 1 . For the first week after the second dose, PC had greater (P ≤ 0.05) feed intake but similar (P > 0.05) growth rate than IC (Fig. 1A  and 1B) . Subsequently, however, feed intake was either similar (P > 0.05) for these 2 genders or greater (P ≤ 0.05) for the IC (Fig. 1B) . In addition, in wk 6, 7, and 8, IC had the highest growth rate of all 4 genders; however, the gender difference was statistically significant (P ≤ 0.05) only for wk 7 (Fig. 1A) . There was no difference between the genders for G:F ratio in any week following the second dose (Fig. 1C) . These results suggest important changes in feed intake and growth rate of IC compared to PC from the second week after the second GnRFA product dose onward that could be of relevance under commercial conditions and that warrant further study.
Effects of Feeding Ractopamine to Immunologically Castrated Barrows
Least-squares means for the IC and IC+RAC treatments are presented in Table 2 where they have been compared using an orthogonal contrast. These 2 treatments had similar (P > 0.05) BW at the start of the study and at the start of the ractopamine feeding period (wk 5 of study); however, IC fed 5 compared to 0 mg/kg ractopamine were 3.6 kg heavier (P ≤ 0.05) at the end of the study period. In addition, feeding 5 compared to 0 mg/ kg ractopamine to IC increased growth rate (142 g/d; 11.6%; P ≤ 0.05) and G:F ratio (0.055 kg:kg; 17.3%; P ≤ 0.001) but had no effect (P > 0.05) on ADFI (Table  2 ) during the ractopamine feeding period. Measured over the overall study period, feeding ractopamine at 5 compared to 0 mg/kg to IC had no effect (P > 0.05) on growth rate or feed intake but increased (P ≤ 0.05) feed efficiency (0.023 kg:kg; 6.2%).
Numerous studies have shown that feeding ractopamine to late finishing pigs increases growth rate and feed efficiency (Uttaro et al., 1993; Armstrong et al., 2004; Patience et al., 2009 ). Apple et al. (2007) performed a meta-analysis of published studies that evaluated feeding ractopamine to finishing pigs, which showed that, averaged across studies, feeding 5 compared to 0 mg/ kg ractopamine resulted in increases in growth rate and feed efficiency of 12 and 10%, respectively. In the current study, the increase in growth rate of IC+RAC was similar to that found by Apple et al. (2007) ; however, the improvement in feed efficiency in IC fed ractopamine (17%) was greater than the average of 10% found in the meta-analysis. The majority of the studies included in the meta-analysis of Apple et al. (2007) used PC and G and the current study is one of the first to evaluate the impact of feeding ractopamine to IC. However, some of the studies included in the meta-analysis of Apple et al. (2007) showed responses in feed efficiency to feeding ractopamine at 5 mg/kg of as great a magnitude as observed in the current study (Stites et al., 1991; Uttaro et al., 1993) . Further research is needed to establish if the responses to the feeding of ractopamine are different in IC compared to other genders.
The results of this study, which was performed in the finishing phase of production, highlighted the growth potential of the IC compared to the PC, particularly in terms of improved feed efficiency. In addition, these results also suggest that the growth performance advantages of the IC compared to the PC continue after the second GnRFA product dose. These results also illustrated the substantial increase in feed efficiency that can be achieved by combining immunological castration of males using GnRFA with the feeding of ractopamine, which, over the study period, amounted to a 17.6% increase in G:F ratio over that of the PC not fed ractopamine. Figure 1 . Effect of gender on weekly growth performance following second gonadotropin releasing factor analog-diphtheria toxoid conjugate (Improvest; Zoetis, Kalamazoo, MI) product dose. a,b Within week, means with different superscripts are different (P ≤ 0.05). (A) Average daily gain, (B) average daily feed intake, and (C) gain:feed ratio.
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